Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma.
Publication
, Journal Article
Staehler, M; Battle, D; Bex, A; Hammers, H; George, D
Published in: Eur Urol
December 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Eur Urol
DOI
EISSN
1873-7560
Publication Date
December 2018
Volume
74
Issue
6
Start / End Page
842 / 843
Location
Switzerland
Related Subject Headings
- Urology & Nephrology
- Sunitinib
- Nephrectomy
- Kidney Neoplasms
- Humans
- Carcinoma, Renal Cell
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Staehler, M., Battle, D., Bex, A., Hammers, H., & George, D. (2018). Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma. Eur Urol, 74(6), 842–843. https://doi.org/10.1016/j.eururo.2018.08.011
Staehler, Michael, Dena Battle, Axel Bex, Hans Hammers, and Daniel George. “Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma.” Eur Urol 74, no. 6 (December 2018): 842–43. https://doi.org/10.1016/j.eururo.2018.08.011.
Staehler M, Battle D, Bex A, Hammers H, George D. Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma. Eur Urol. 2018 Dec;74(6):842–3.
Staehler, Michael, et al. “Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma.” Eur Urol, vol. 74, no. 6, Dec. 2018, pp. 842–43. Pubmed, doi:10.1016/j.eururo.2018.08.011.
Staehler M, Battle D, Bex A, Hammers H, George D. Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma. Eur Urol. 2018 Dec;74(6):842–843.
Published In
Eur Urol
DOI
EISSN
1873-7560
Publication Date
December 2018
Volume
74
Issue
6
Start / End Page
842 / 843
Location
Switzerland
Related Subject Headings
- Urology & Nephrology
- Sunitinib
- Nephrectomy
- Kidney Neoplasms
- Humans
- Carcinoma, Renal Cell
- 3202 Clinical sciences
- 1103 Clinical Sciences